These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 29468553)

  • 1. CRISPR/Cas9-Mediated Knockout of Rb1 in Xenopus tropicalis.
    Naert T; Vleminckx K
    Methods Mol Biol; 2018; 1726():177-193. PubMed ID: 29468553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas9 mediated knockout of rb1 and rbl1 leads to rapid and penetrant retinoblastoma development in Xenopus tropicalis.
    Naert T; Colpaert R; Van Nieuwenhuysen T; Dimitrakopoulou D; Leoen J; Haustraete J; Boel A; Steyaert W; Lepez T; Deforce D; Willaert A; Creytens D; Vleminckx K
    Sci Rep; 2016 Oct; 6():35264. PubMed ID: 27739525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Simple Protocol for Loss-of-Function Analysis in Xenopus tropicalis Founders Using the CRISPR-Cas System.
    Sakane Y; Suzuki KT; Yamamoto T
    Methods Mol Biol; 2017; 1630():189-203. PubMed ID: 28643260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Models in Xenopus tropicalis by CRISPR/Cas9 Mediated Knockout of Tumor Suppressors.
    Naert T; Vleminckx K
    Methods Mol Biol; 2018; 1865():147-161. PubMed ID: 30151765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods for CRISPR/Cas9 Xenopus tropicalis Tissue-Specific Multiplex Genome Engineering.
    Naert T; Vleminckx K
    Methods Mol Biol; 2018; 1865():33-54. PubMed ID: 30151757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TALENs and CRISPR/Cas9 fuel genetically engineered clinically relevant Xenopus tropicalis tumor models.
    Naert T; Van Nieuwenhuysen T; Vleminckx K
    Genesis; 2017 Jan; 55(1-2):. PubMed ID: 28095622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotyping of CRISPR/Cas9 Genome Edited Xenopus tropicalis.
    Naert T; Vleminckx K
    Methods Mol Biol; 2018; 1865():67-82. PubMed ID: 30151759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient RNA/Cas9-mediated genome editing in Xenopus tropicalis.
    Guo X; Zhang T; Hu Z; Zhang Y; Shi Z; Wang Q; Cui Y; Wang F; Zhao H; Chen Y
    Development; 2014 Feb; 141(3):707-14. PubMed ID: 24401372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid and efficient analysis of gene function using CRISPR-Cas9 in Xenopus tropicalis founders.
    Shigeta M; Sakane Y; Iida M; Suzuki M; Kashiwagi K; Kashiwagi A; Fujii S; Yamamoto T; Suzuki KT
    Genes Cells; 2016 Jul; 21(7):755-71. PubMed ID: 27219625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-efficiency non-mosaic CRISPR-mediated knock-in and indel mutation in F0
    Aslan Y; Tadjuidje E; Zorn AM; Cha SW
    Development; 2017 Aug; 144(15):2852-2858. PubMed ID: 28694259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient genome editing of genes involved in neural crest development using the CRISPR/Cas9 system in Xenopus embryos.
    Liu Z; Cheng TT; Shi Z; Liu Z; Lei Y; Wang C; Shi W; Chen X; Qi X; Cai D; Feng B; Deng Y; Chen Y; Zhao H
    Cell Biosci; 2016; 6():22. PubMed ID: 27042291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RBL1 (p107) functions as tumor suppressor in glioblastoma and small-cell pancreatic neuroendocrine carcinoma in Xenopus tropicalis.
    Naert T; Dimitrakopoulou D; Tulkens D; Demuynck S; Carron M; Noelanders R; Eeckhout L; Van Isterdael G; Deforce D; Vanhove C; Van Dorpe J; Creytens D; Vleminckx K
    Oncogene; 2020 Mar; 39(13):2692-2706. PubMed ID: 32001819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biallelic genome modification in F(0) Xenopus tropicalis embryos using the CRISPR/Cas system.
    Blitz IL; Biesinger J; Xie X; Cho KW
    Genesis; 2013 Dec; 51(12):827-34. PubMed ID: 24123579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simple and efficient CRISPR/Cas9-mediated targeted mutagenesis in Xenopus tropicalis.
    Nakayama T; Fish MB; Fisher M; Oomen-Hajagos J; Thomsen GH; Grainger RM
    Genesis; 2013 Dec; 51(12):835-43. PubMed ID: 24123613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas9 Mutagenesis in
    Blitz IL; Nakayama T
    Cold Spring Harb Protoc; 2022 Mar; 2022(3):. PubMed ID: 34244352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding the genetic toolkit in Xenopus: Approaches and opportunities for human disease modeling.
    Tandon P; Conlon F; Furlow JD; Horb ME
    Dev Biol; 2017 Jun; 426(2):325-335. PubMed ID: 27109192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of human embryonic stem cell line with heterozygous RB1 deletion by CRIPSR/Cas9 nickase.
    Tu J; Huo Z; Liu M; Wang D; Xu A; Zhou R; Zhu D; Gingold J; Shen J; Zhao R; Lee DF
    Stem Cell Res; 2018 Apr; 28():29-32. PubMed ID: 29414415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly Efficient Genome Editing via CRISPR/Cas9 to Create Clock Gene Knockout Cells.
    Korge S; Grudziecki A; Kramer A
    J Biol Rhythms; 2015 Oct; 30(5):389-95. PubMed ID: 26243628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9-mediated gene manipulation to create single-amino-acid-substituted and floxed mice with a cloning-free method.
    Ma X; Chen C; Veevers J; Zhou X; Ross RS; Feng W; Chen J
    Sci Rep; 2017 Feb; 7():42244. PubMed ID: 28176880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding the CRISPR/Cas genome-editing scope in Xenopus tropicalis.
    Shi Z; Jiang H; Liu G; Shi S; Zhang X; Chen Y
    Cell Biosci; 2022 Jul; 12(1):104. PubMed ID: 35804405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.